Clinical Trials Sponsored by NovImmune SA
Total 1046 results
-
Light Chain Bioscience - Novimmune SARecruitingTriple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-squamous Non-small-cell Lung CancerItaly, France
-
Light Chain Bioscience - Novimmune SACompletedRheumatoid ArthritisSerbia, Bosnia and Herzegovina, Bulgaria, Georgia, Hungary, Moldova, Republic of, Poland
-
Light Chain Bioscience - Novimmune SACompleted
-
Light Chain Bioscience - Novimmune SACompletedModerate to Severe Crohn's Disease
-
Light Chain Bioscience - Novimmune SACompleted
-
Light Chain Bioscience - Novimmune SATerminatedPrimary Biliary CirrhosisItaly, United Kingdom
-
Light Chain Bioscience - Novimmune SACompletedAllergic Contact Dermatitis
-
Light Chain Bioscience - Novimmune SACompleted
-
Swedish Orphan BiovitrumLight Chain Bioscience - Novimmune SATerminatedHemophagocytic LymphohistiocytosesUnited States
-
Light Chain Bioscience - Novimmune SAM.D. Anderson Cancer CenterCompletedHemophagocytic LymphohistiocytosisUnited States
-
CoImmuneTerminatedAdvanced Renal Cell CarcinomaUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
NexImmune Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
NexImmune Inc.Not yet recruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma | Oropharyngeal Cancer | Human Papilloma Virus | Head and Neck Cancer Metastatic | HPV-Related Squamous Cell Carcinoma | Oropharyngeal Cancer, Metastatic | HPV-Related Mucosal Head and Neck Squamous... and other conditions
-
NImmune BiopharmaCompletedUlcerative ColitisUnited States, Bosnia and Herzegovina, Croatia, Poland, Ukraine
-
NImmune BiopharmaWithdrawnEosinophilic Esophagitis
-
NImmune BiopharmaCompletedSafety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female VolunteersNormal Healthy VolunteersUnited States
-
NatImmune A/SUnknownCutaneous WartsDenmark
-
NImmune BiopharmaTerminatedCrohn's DiseaseUnited States
-
NImmune BiopharmaCompletedNormal Healthy VolunteersAustralia
-
NImmune BiopharmaWithdrawn
-
RevimmuneAmarex Clinical ResearchTerminatedCOVID-19 | LymphocytopeniaUnited Kingdom
-
Sankom SAInterMedService SA; Pharmaxi LLCUnknownChronic Venous InsufficiencyUkraine
-
Aptissen SARecruiting
-
Aktiia SARecruitingHypertension | Blood Pressure | Heart RateSwitzerland
-
Firalis SANot yet recruiting
-
Amazentis SARecruitingHealthy | Healthy Aging | Healthy DietUnited States
-
Axalbion SARecruiting
-
Firalis SACompletedAMI PatientsFrance, Korea, Republic of
-
Cellaion SATerminatedAcute on Chronic Liver FailureBelgium, Spain, France, Austria, Denmark, Latvia, Germany, Bulgaria, Poland, Estonia, Italy, Lithuania, North Macedonia, Slovakia
-
Teoxane SACompleted
-
Maxivax SAActive, not recruiting
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Amazentis SACompleted
-
Phargentis SACompleted
-
Cryotherapeutics SAWithdrawnAcute Coronary SyndromeDenmark, Sweden
-
Abionic SACompleted
-
Stalicla SACompletedAutism Spectrum DisorderUnited States
-
Stalicla SAWithdrawnAutism Spectrum DisorderUnited States
-
ObsEva SACompletedEndometriosisUnited States, Poland, Russian Federation, Ukraine
-
Sintetica SACompletedHealthy VolunteersAustria
-
Stalicla SACompletedAutism Spectrum DisorderUnited States
-
Sintetica SACompletedHealthy SubjectsSwitzerland
-
Spineart SATerminated
-
Anecova SACompletedEndometrial FluidSpain
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Combioxin SACompletedPneumonia | Pneumococcal InfectionsFrance, Belgium
-
ObsEva SACompletedHepatic Impairment | Healthy ParticipantsUnited States